Here are the companies making headlines in extending trading.



a statue of a person riding a horse: A child wearing a face mask sits on the Charging Bull statue, also known as the Wall Street Bull, following the outbreak of the coronavirus disease (COVID-19) in New York, August 19, 2020.


© Provided by CNBC
A child wearing a face mask sits on the Charging Bull statue, also known as the Wall Street Bull, following the outbreak of the coronavirus disease (COVID-19) in New York, August 19, 2020.

Novavax — Shares of the biotech company rose more than 4% after Novavax announced that it had started a phase three trial in the United Kingdom for its coronavirus vaccine candidate. Novavax said the trial would involve up to 10,000 patients over the next four to six weeks.

Loading...

Load Error

Costco — Shares of the retailer fell 2.6% after reporting its results for its fiscal fourth quarter. The company reported $53.38 billion of revenue, $1.3 billion above what analysts were expecting, according to Refinitv. Costco also beat earnings estimates, reporting adjusted earnings per share of $3.04 versus $2.84 expected. The company said it had $281 million of expenses related to the pandemic.

Bristol-Myers Squibb — The pharmaceutical stock gained 3% in extended trading after the company announced positive results from a phase three trial of its immunotherapy Opdivo for bladder cancer patients. The trial will continue for the investigators to gather more data.  

Video: Target same-store sales climb by 24.3% in blowout second quarter (CNBC)

Target same-store sales climb by 24.3% in blowout second quarter

UP NEXT

UP NEXT

Continue Reading

Source Article